Venetoclax, Ponatinib, and Dexamethasone in Participants With Philadelphia Chromosome or BCR-ABL Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Otsuka Beijing Research Institute
OHSU Knight Cancer Institute
Hospices Civils de Lyon